29) Chari R, Coe BP, Vucic EA, Lockwood WW, Lam WW (2010) An integrative multi-dimensional genetic and epigenetic strategy to identify
aberrant genes and pathways in cancer.
It is a genetic disease caused when a child carries two copies of
an aberrant gene — one copy from each parent.
Not exact matches
That's not to say
gene editing is new (it isn't), but Crispr simplifies the process by using molecular scissors that can be precisely targeted to snip out
aberrant regions of genetic code, which can then be replaced with the correct sequences.
There's the challenge of CRISPR» ing an unprecedented number of
genes without compromising the viability of the designer pigs and without introducing
aberrant edits.
The scientists have shown that, in all cancers, a sort of «identity crisis» is observed in cancerous cells: in the organs or tissues in which a tumor develops,
genes specific to other tissues or to other stages of the development of the organism express themselves in an
aberrant manner.
From a more fundamental viewpoint, the researchers still need to explain the relationship between the
aberrant expression of these
genes and the virulence of the cancer.
The scientists have shown that, in all cancers, an
aberrant activation of numerous
genes specific to other tissues occurs.
This work provides a proof of principle for a new approach in the study and treatment of cancer: the
aberrant expression in a tissue or organ of
genes specific to other tissues could become a new tool for establishing a prognosis and personalizing therapeutic care.
The researchers bred together mice that each carried one normal copy of the
gene and one
aberrant copy — that is, they were heterozygous.
The
aberrant and ongoing activation of ERVs caused an accumulation of retroviral proteins in the affected cells and deregulation of
genes and pathways.
In cancers, both
gene mutations and
aberrant regulation of
genes (promoter inhibition by methylation of DNA) are known to play pivotal roles regulating cancer growth.
The mutated
gene, FAA, codes for an
aberrant, as - yet - unnamed protein that initiates a cascade of malfunctions in various body systems, including production of blood cells and platelets in the bone marrow.
Some researchers have conjectured, however, that the normal WS protein quashes formation of
aberrant DNA structures in humans, a process that might go awry when the
gene suffers a mutation.
This is an example of normal
genes put together in an
aberrant situation.
With these tools, Verma is revealing how the
aberrant expression of normal cellular
genes can causes tumors.
Furthermore, high - resolution analysis of cytosine methylation in primary and transformed cells has found less
aberrant methylation of CpG island promoters in transformed cells than had been previously hypothesized based on candidate
gene studies [58].
Targeted disruption of IRF - 1 or IRF - 2 results in abnormal type I IFN
gene induction and
aberrant lymphocyte development.
The
gene encodes a protein called plakophilin 2, which is crucial for the formation and proper functioning of the skin structure, suggesting an
aberrant skin barrier as a potential risk factor for atopic dermatitis.
lentiviral vectors contain a deletion in the 3» LTR that prevents
aberrant activation of nearby
genes.
In the article describing the work in Molecular Therapy, co-authors Charis Himeda, Takako Jones and Peter Jones highlight the important implications for similar types of genetic diseases: «With increasing evidence that the repeat genome (comprising nearly half the human genome) plays important roles in
gene regulation, additional diseases will likely be found associated with
aberrant repetitive genomic sequences,» they write.
Additionally, alterations of subcellular localization through
aberrant splicing or genetic mutations also provide ways to inactivate tumor suppressor
genes (50).
This is believed to be true given the results of previous RNA - seq experiments (1, 4, 5) along with a belief that the odds are very low that Cas9 would have an off - target that lands in the promoter of another
gene, thereby driving
aberrant transcription.
A hallmark of the Notch pathway is its
gene dosage sensitivity, such that small differences in the amount of Notch activity can cause
aberrant cell fate choices and T - cell leukemia.
This is in accordance with previous reports that decitabine and 5 - azacytidine produce a marked synergistic effect in combination with suberoylanilide hydroxamic acid and romidepsin in T - lymphoma cell lines by modulating cell cycle arrest and apoptosis.26, 27 As a mechanism of action, KMT2D mutations of B - lymphoma cells promote malignant outgrowth by perturbing methylation of H3K4 that affect the JAK - STAT, Toll - like receptor, or B - cell receptor pathway.28, 29 Here our study indicated that dual treatment with chidamide and decitabine enhanced the interaction of KMT2D with the transcription factor PU.1, thereby inactivating the H3K4me - associated signaling pathway MAPK, which is constitutively activated in T - cell lymphoma.13, 30,31 The transcription factor PU.1 is involved in the development of all hematopoietic lineages32 and regulates lymphoid cell growth and transformation.33
Aberrant PU.1 expression promotes acute myeloid leukemia and is related to the pathogenesis of multiple myeloma via the MAPK pathway.34, 35 On the other hand, PU.1 is also shown to interact with chromatin remodeler and DNA methyltransferease to control hematopoiesis and suppress leukemia.36 Our data thus suggested that the combined action of chidamide and decitabine may interfere with the differentiation and / or viability of PTCL - NOS through a PU.1 - dependent
gene expression program.
A possible explanation for this finding is that residual mRNA expression from oocytes was still present in morula stage parthenotes and / or chemical activation induced the
aberrant expression of certain
genes in parthenotes.
Aberrant beta - catenin - TCF target
gene activation plays a major role in colorectal cancer development.
A recurring theme is the overlap of these core «multicellularity»
genes with
genes perturbed in cancer, a disease of
aberrant multicellularity (see oncogenes and tumour suppressors in Figs 2 and 3).
Her graduate work culminated in multiple publications in the field of cancer epigenetics and in a thesis entitled «
Aberrant epigenetic silencing of tumor suppressor
genes in human cancer: the roles of DNA hypermethylation and the histone code.»
«The data show that
aberrant epigenetic
gene programming can now be considered a hallmark of acute lymphoblastic leukemia, occurring in all patients regardless of the presence of genetic mutations,» Melnick said.
In cancers,
aberrant promoter CpG island hypermethylation correlates highly with
gene inactivation and can account for lack of
gene expression where mutations do not exist.